Obi Toppin

Public perception around Obi Toppin sits at a cautious C+ right now — not a free fall, but hardly a ringing endorsement for a 28-year-old power forward who should be entering his prime years. The dominant narrative heading into the 2025-26 season has been his foot surgery, which will sideline him for at least three months and immediately reframed the conversation from developmental progress to durability questions — a brutal shift for a player whose contract talks had reportedly been moving in the right direction. His underlying profile still gives analysts something to hold onto: through 14 games in the 2025-26 season, Toppin was producing 9.0 PPG, 4.1 RPG, and 2.1 APG, numbers that align with his C performance grade as a solid rotation piece rather than a difference-maker, but credible enough to suggest real value when healthy. The Pacers' recent roster activity — acquiring Ivica Zubac and Kobe Brown via trade — further clouds Toppin's path back to a meaningful role, since that frontcourt infusion suggests Indiana isn't simply waiting around for his return. With the Pacers at 19-63 and sitting at the 14th seed in the East, the stakes around any individual player's timeline feel somewhat removed from urgency, but that context cuts both ways — there's less pressure, yet also less clarity about what his role even looks like once he's cleared to play. The narrative today is best described as cautiously pessimistic and firmly in wait-and-see territory, with fan and media sentiment unlikely to meaningfully shift until Toppin is back on the floor and reclaiming minutes in Rick Carlisle's rotation.